IP Library Granted Patent US 10,710,963
Granted Patent B2
US 10,710,963 · App. 16/226,763 · Granted Jul 14, 2020

Chemical compounds

Inventors: Philip Stewart Turnbull (Research Triangle Park, NC); Rodolfo Cadilla (Research Triangle Park, NC)
Assignee: GlaxoSmithKline Intellectual Property (No.2) Limited
C07D209/14A61K31/404C07D209/08C07D209/10C07D209/42C07D401/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,710,963
App. No.
16/226,763
Granted
Jul 14, 2020
Kind
B2
Abstract

This invention relates to non-steroidal compounds that are modulators of androgen receptor, and also to the methods for the making and use of such compounds.

Claims (6)

1. A method of treating periodontal disease, wherein said method comprises administering the compound:

to a human subject in need thereof.

2. The method according to claim 1 , wherein 0.1-50 mgs of the compound is administered.

3. A method of treating chronic fatigue syndrome, wherein said method comprises administering the compound:

to a human subject in need thereof.

4. The method according to claim 3 , wherein 0.1-50 mgs of the compound is administered.

Assignments (1)
CHANGE OF ADDRESS Recorded Apr 16, 2025
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 070854/0469 →
Continuity (6)
Continuation 15358458 · Nov 22, 2016
Continuation 14549034 · Nov 20, 2014
Continuation 13941911 · Jul 15, 2013
Provisional Application 61748874 · Jan 4, 2013
Provisional Application 61672455 · Jul 17, 2012
Related Publication 20190127326A1 · May 2, 2019